A COMPREHENSIVE SERIES OF ARTICLES ON THIS TOPIC
Leading US generic drugmaker Perrigo has formally completed its $8.6bn (€6.5bn) takeover of Irish biotech firm Elan in a cash and share deal.
Fri, 20 Dec, 2013
US pharmaceutical Perrigo will benefit from around $150m (€113m) in annual tax savings from acquiring Elan, its chief executive said yesterday.
Tue, 30 Jul, 2013
Thursday, February 2, 2023 - 9:00 PM
Thursday, February 2, 2023 - 11:00 AM